OPEONGO
Live / Applied — New application — not yet assigned to an examiner (as of 01 Sept 2026)
What this means for you
Not registered yet, but its 01 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50083285
- Mark type
- Word mark
- Filed
- 01 Sept 2026
- Attorney of record
- Roy D. Gross
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer; Antibodies for medical purposes; Therapeutic antibodies for the treatment of: extracellular matrix diseases, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, regeneration disorders and cancer
- Class 042 — Scientific and technological services: Drug discovery services; Biochemical analysis services in the field of drug discovery; Biochemical analysis services in the field of medical diagnosis of disease; Biochemical analysis services in the field of drug target discovery; Pharmaceutical drug development services; Drug discovery services for: modulation of the extracellular matrix, prevention and treatment of fibrotic diseases, treating inflammatory diseases, treating age-related diseases, treating degenerative diseases, treating tissue repair, treating regeneration disorders, and chemotherapy; Scientific research for medical purposes in the area of fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, regeneration disorders; Biomedical research in the field of the extra cellular matrix and fibrosis; providing online non-downloadable software for modeling the extracellular matrix for use in drug and target discovery; providing online non-downloadable software for drug discovery in the field of: fibrosis, cancerous diseases, modulation of the extracellular matrix, fibrotic diseases, inflammatory diseases, age-related diseases, degenerative diseases, tissue repair, and regeneration disorders
Owner
- Opeongo, Inc., Coral Gables, FL, US
Prosecution history
- 28 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 01 Sept 2026 — NEW APPLICATION ENTERED